Company / Book Value per Share
Vanda Pharmaceuticals Inc. Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$9.236
FY2025
5-year range
$7.49 / $9.236
FY2021-FY2025
Trend
+0.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has increased for 6 consecutive years, from $2.504 in FY2019 to $9.236 in FY2025.
Based on SEC 10-K filings.
$9.236 in FY2025 with a 5-year CAGR of +12.4%.
Improved from $8.892 to $9.236 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +4.4%
- 5-Year CAGR
- +12.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Vanda Pharmaceuticals Inc.'s book value per share has grown for 6 consecutive years.
- 5-year CAGR of +12.4%, indicating consistent growth.
- In FY2025, book value per share increased 0.8% year-over-year.
- Lowest book value per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.236 | +0.8% |
| FY2024 | $9.163 | +3.0% |
| FY2023 | $8.892 | +9.7% |
| FY2022 | $8.108 | +8.3% |
| FY2021 | $7.49 | +45.6% |
| FY2020 | $5.143 | +105.4% |
| FY2019 | $2.504 | -14.3% |
| FY2018 | $2.922 | -3.3% |
| FY2017 | $3.023 | -19.5% |
| FY2016 | $3.756 | +253.2% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026